Artelo Biosciences, Inc. (NASDAQ:ARTL – Get Free Report) was the target of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 6,100 shares, a decline of 57.9% from the March 31st total of 14,500 shares. Based on an average trading volume of 14,800 shares, the short-interest ratio is currently 0.4 days. Currently, 0.2% of the company’s stock are sold short.
Analyst Ratings Changes
Separately, HC Wainwright restated a “buy” rating and set a $5.00 price target on shares of Artelo Biosciences in a research note on Tuesday, April 2nd.
View Our Latest Analysis on ARTL
Artelo Biosciences Stock Performance
Artelo Biosciences (NASDAQ:ARTL – Get Free Report) last issued its earnings results on Monday, March 25th. The company reported ($0.99) EPS for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.70). On average, equities analysts expect that Artelo Biosciences will post -2.07 earnings per share for the current fiscal year.
Artelo Biosciences Company Profile
Artelo Biosciences, Inc, a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD.
Featured Stories
- Five stocks we like better than Artelo Biosciences
- NYSE Stocks Give Investors a Variety of Quality Options
- MarketBeat Week in Review – 4/22 – 4/26
- What Is WallStreetBets and What Stocks Are They Targeting?
- 3 Stocks Leading the U.S. Agriculture Comeback
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Artelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.